The research, published in the Journal of the American Medical Association on Monday, looked at 1,438 patients from 25 hospitals in New York state between March 15 and March 28. Of those, 735 patients received hydroxychloroquine with azithromycin, 271 were given hydroxychloroquine alone, 211 received just azithromycin and 221 acted as a control group.
“[T]he fast moving public health implications of the COVID-19 pandemic necessitates that we examine potential treatments for the disease in the most rapid yet careful manner possible," the Dean of the School of Public Health at University at Albany, David Holtgrave, said in a statement obtained by Fox News. "This observational study has given us an important early look at some key questions related to prescribing patterns of hydroxychloroquine, azithromycin and chloroquine. Unfortunately, we did not observe benefits of the most used drug (hydroxychloroquine with or without azithromycin) in this group of seriously ill, hospitalized patients.”
https://www.foxnews.com/science/hydroxychloroquine-no-benefits-seriously-ill-coronavirus-patients